Skip to main content

Table 3 Univariate and multivariate Cox analysis for endpoints

From: Predictive value of gamma-glutamyltransferase for ventricular arrhythmias and cardiovascular mortality in implantable cardioverter-defibrillator patients

 

HR

95%CI

P value

univariate analysis

 VAs

  GGT ≥ 56 U/L

2.429

1.542–3.826

<0.001

 shock

  GGT ≥ 56 U/L

2.161

1.234–3.784

0.007

 cardiac death

  GGT ≥ 56 U/L

4.171

1.515–11.483

0.006

multivariate analysis

 VAsa

  GGT ≥ 56 U/L

2.253

1.383–3.671

0.001

  Diabetes

3.168

1.082–9.276

0.035

 shockb

  GGT ≥ 56 U/L

2.256

1.219–4.176

0.010

  LVEDD

1.026

1.003–1.050

0.029

 cardiac deathc

  GGT ≥ 56 U/L

3.555

1.215–10.404

0.021

  Diabetes

5.725

1.191–27.515

0.029

  1. a adjusted for age, gender, LVEDD, ischemic cardiomyopathy, diabetes, GGT ≥ 56 U/L
  2. b adjusted for age, gender, LVEDD, ischemic cardiomyopathy, GGT ≥ 56 U/L
  3. c adjusted for age, gender, LVEDD, left ventricular ejection fraction, diabetes, GGT ≥ 56 U/L
  4. Abbreviations: VAs ventricular arrhythmias, HR hazard ratio, CI confidence interval, GGT gamma-glutamyltransferase, LVEDD left ventricular end-diastolic diameter